CEO's Column
Search
More
AI Funding
Breaking News
Optura Raises $6.5M to Build AI Operating System
Optura Raises $6.5M to Build AI Operating System
Landing Img
2 months ago

Optura Raises $6.5M to Build AI Operating System

Optura, a healthcare-focused AI enterprise platform based in Nashville, Tennessee, has raised $6.5 million in seed funding. The round was co-led by Susa Ventures and Matrix Partners, signaling strong investor confidence in the company’s mission to modernize healthcare operations using intelligent automation. Powering Healthcare with Purpose-Built AI Agents Optura plans...

Landing Img
2 months ago

Biostate AI Raises $12M Series A to Advance AI-Powered RNA Sequencing

Biostate AI, a pioneering biotech startup, has raised $12 million in a Series A funding round. The investment was led by Accel, with participation from Gaingels, Mana Ventures, InfoEdge Ventures, and returning investors such as Matter Venture Partners, Vision Plus Capital, and Catapult Ventures. Notable angel investors from leading biotech...

Landing Img
4 months ago

Incident.io Secures $62 Million to Transform Incident Management with AI Agents

Incident.io, a rapidly growing incident management platform used by tech giants Netflix, Linear, Ramp, and Etsy, has raised a $62 million Series B round of funding. The investment was led by Insight Partners, a global software investor, with additional support from Index Ventures and Point Nine Capital, taking the company's...

Landing Img
4 months ago

Isomorphic Labs Secures $600 Million to Advance AI-Driven Drug Discovery

Isomorphic Labs, a biotech company focused on AI-first drug design and development, has announced the close of its first external funding round, raising $600 million. The investment was led by Thrive Capital with participation from GV and additional backing from existing investor Alphabet.The funding is intended to transform the pharmaceutical...

More Articles
No news available.
More Articles
No news available.

Subscribe to NG.ai News for real-time AI insights, personalized updates, and expert analysis—delivered straight to your inbox.